Stock listing

LS Exchange:A403QV Biophytis SA Aktie

German listing (LS Exchange) of Biophytis SA · home listing Euronext:ALBPS

Follow Biophytis SA into a list and get an email when it puts out news.

Home listing price · EURONEXT:ALBPS

€0.03 EUR -0.00 (-1.9%)

Close on Nov 20, 2026 · This listing has no price on 6ix; the price shown is the home listing's, EURONEXT:ALBPS

Past year -61.8% · daily closes, Nov 20, 2025 – Nov 20, 2026, adjusted for splits
Day range
€0.03 – €0.034 EURNov 20, 2026
Volume
17.20M sharesNov 20, 2026
Market cap
€11.37M EURAt the close on Nov 20, 2026 · price × 373.9M shares outstanding
52-week range
€0.0042 – €0.16 EURLowest and highest trades, Nov 21, 2025 – Nov 20, 2026
Traded on an average day
€1.57M EURMedian day 16.09M shares · last 3 months, Aug 20, 2026 – Nov 20, 2026
Biophytis SA logo

Prices by listing

ListingLastChangeVolumeOpenHighLowPrevious closePrice from
Euronext:ALBPS · Home€0.03 EUR-0.001 (-1.9%)17,195,832€0.032€0.034€0.03€0.031Close on Nov 20, 2026
OTC:BPTSY$0.40 USD0.00 (0.0%)3,000$0.40$0.40$0.40$0.40Close on Nov 6, 2026
Frankfurt:6XB3€0.01 EUR-0.001 (-5.5%)—€0.012€0.012€0.01€0.011Close on Nov 20, 2026

Daily closes

Last 3 months, Aug 20, 2026 – Nov 20, 2026 · EURONEXT:ALBPS · EUR, adjusted for splits

DayCloseChange%OpenHighLowVolume
€0.03-0.001-1.9%€0.032€0.034€0.0317,195,832
€0.031-0.003-8.6%€0.033€0.033€0.0311,775,643
€0.034-0.001-2.3%€0.033€0.034€0.0337,533,397
€0.035-0.003-7.0%€0.037€0.039€0.03314,991,847
€0.037-0.002-5.1%€0.039€0.041€0.03714,940,936
€0.039-0.002-4.4%€0.042€0.043€0.03714,937,156
€0.0410.00-0.5%€0.042€0.044€0.03814,019,801
€0.041-0.004-8.0%€0.046€0.046€0.0422,973,867
€0.045+0.003+5.9%€0.054€0.056€0.04380,443,120
€0.042+0.002+5.5%€0.04€0.045€0.03839,875,120
€0.04+0.00+1.0%€0.043€0.055€0.04143,391,109
€0.04+0.014+54.3%€0.029€0.041€0.027121,304,578
€0.026-0.003-9.8%€0.03€0.03€0.02417,847,652
€0.029-0.002-7.1%€0.031€0.031€0.02810,821,724
€0.031-0.003-7.8%€0.033€0.033€0.0310,345,226
€0.033-0.001-1.5%€0.034€0.034€0.0328,905,764
€0.0340.00-0.6%€0.035€0.035€0.0335,886,298
€0.034+0.00+0.6%€0.035€0.036€0.0345,886,746
€0.034-0.001-2.0%€0.035€0.038€0.03314,255,852
€0.035+0.003+8.8%€0.033€0.038€0.03227,447,766
€0.032-0.002-6.5%€0.034€0.034€0.0328,162,707
€0.034+0.00+1.2%€0.034€0.036€0.0314,269,925
€0.034-0.006-14.9%€0.039€0.04€0.02537,404,281
€0.040.00-0.8%€0.041€0.041€0.0385,864,453
€0.04-0.003-6.1%€0.041€0.042€0.047,740,076
€0.042-0.002-3.6%€0.043€0.043€0.0411,166,215
€0.044-0.002-3.9%€0.046€0.048€0.04311,918,285
€0.0460.00-0.9%€0.046€0.047€0.0463,366,189
€0.046-0.003-5.1%€0.048€0.049€0.0467,231,203
€0.049+0.002+4.1%€0.045€0.049€0.04510,797,186
€0.047-0.001-2.5%€0.049€0.049€0.0457,025,761
€0.048+0.001+2.1%€0.046€0.058€0.04630,325,488
€0.047-0.001-1.9%€0.048€0.048€0.0465,414,183
€0.048+0.003+5.7%€0.047€0.05€0.0469,521,121
€0.045-0.002-4.2%€0.047€0.048€0.0459,090,593
€0.047-0.002-3.5%€0.049€0.05€0.04714,819,902
€0.049-0.005-9.3%€0.051€0.054€0.04818,483,826
€0.054+0.008+16.1%€0.048€0.054€0.04735,367,328
€0.0470.000.0%€0.046€0.048€0.04412,247,614
€0.047-0.002-3.5%€0.048€0.048€0.0466,348,009
€0.048-0.002-4.2%€0.049€0.051€0.0476,160,604
€0.05+0.003+6.3%€0.047€0.051€0.04613,317,239
€0.047-0.002-3.5%€0.049€0.049€0.04612,384,409
€0.049-0.002-3.4%€0.049€0.053€0.04811,802,698
€0.051-0.001-1.0%€0.054€0.056€0.04918,180,805
€0.051+0.005+11.8%€0.046€0.054€0.04534,017,773
€0.046-0.005-9.8%€0.05€0.05€0.04519,660,420
€0.051+0.001+1.6%€0.05€0.055€0.04729,071,721
€0.05-0.002-4.8%€0.055€0.056€0.04920,038,447
€0.053-0.014-21.4%€0.052€0.058€0.0584,912,781
€0.067-0.001-1.3%€0.068€0.074€0.06414,077,169
€0.068-0.005-6.6%€0.078€0.079€0.06725,012,223
€0.073+0.002+3.6%€0.07€0.081€0.06446,236,371
€0.07-0.007-9.2%€0.08€0.08€0.06837,513,793
€0.077+0.00+0.5%€0.078€0.095€0.06894,655,180
€0.077+0.024+44.2%€0.057€0.077€0.05282,404,945
€0.053+0.001+1.1%€0.05€0.057€0.04439,703,402
€0.053-0.005-9.5%€0.061€0.061€0.04926,502,721
€0.058+0.006+10.9%€0.052€0.074€0.05266,045,617
€0.052-0.012-18.8%€0.065€0.065€0.05233,285,340
€0.065-0.01-13.5%€0.074€0.074€0.06234,365,914
€0.075-0.005-6.8%€0.09€0.092€0.07231,612,416
€0.08+0.001+1.0%€0.079€0.096€0.06658,715,879
€0.079-0.026-24.6%€0.094€0.095€0.07846,221,801
€0.105-0.021-16.7%€0.117€0.118€0.09934,738,602
€0.126-0.006-4.5%€0.132€0.141€0.09560,377,586

Splits

1 split · EURONEXT:ALBPS · every price before a split is adjusted for it

DayRatioWhat
1-for-400Consolidation
Ticker
LS Exchange:A403QV
Asset type
Stock
Sector
Health care
Industry
Biotechnology
Exchange
LS Exchange
Currency
EUR

What changed lately

Latest news

All Biophytis SA news

Biophytis SA on 6ix

Sector
Health care
Industry
Biotechnology
News releases
17 in the last 12 months · 28 in all · newest Nov 12, 2026 · oldest 2025
Decks
35 decks · latest August 2026

Where Biophytis SA is listed

ListingExchangeCountryCurrency
Euronext:ALBPS · Home listingEuronextFranceEUR
LSE:0D1WLSEUnited KingdomEUR
LS Exchange:A403QV · This pageLS ExchangeGermanyEUR
OTC:BPTSYOTCUnited StatesUSD
Lang & Schwarz:A403QVLang & SchwarzGermanyEUR
gettex:6XB3gettexGermanyEUR
Frankfurt:6XB3FrankfurtGermanyEUR
Munich:6XB3MunichGermanyEUR
Turquoise:ALBPSPTurquoiseUnited KingdomEUR
Stuttgart:6XB3StuttgartGermanyEUR

Valuation

balance Jun 30, 2025 · price Nov 20, 2026

Enterprise value
€17.72M EUR
P/E
Not reported
EV/sales
No revenue
EV/EBITDA
No depreciation figure on 6ix yet
Price/book
Negative equity
Gross margin
No revenue
Operating margin
No revenue
Net margin
No revenue
Debt to equity
Negative equity
Beta
No index for this market yet

Biotechnology: the 10 companies nearest in size, of 890 on 6ix with figures. Size in US dollars.

CompanyMkt capEVP/EEV/SalesEV/EBITDAP/BNet mgnDebt/EqBeta
Biophytis SA · EURONEXT:ALBPSUS$12.47MUS$19.44Mn/an/an/an/an/an/an/a
Devonian Health Group, Inc. · TSXV:GSDUS$13.09MUS$12.59Mn/a6.0×n/a2.7×−204.1%0.0×0.12
Bolt Biotherapeutics, Inc. · NASDAQ:BOLTUS$12.80MUS$18.89Mn/a7.5×n/a1.5×n/a2.4×0.52
Avai Bio, Inc. · OTC:AVAIUS$12.79MUS$12.67Mn/an/an/an/an/an/a0.28
Neuphoria Therapeutics Inc. · NASDAQ:NEUPUS$12.72M−US$6.03Mn/an/an/a0.5×n/a0.0×0.61
Seres Therapeutics, Inc. · NASDAQ:MCRBUS$12.64MUS$30.89Mn/a14.5×n/a0.6×n/a1.7×1.21
Passage Bio, Inc. · NASDAQ:PASGUS$12.61M−US$7.55Mn/an/an/a252×n/a0.0×1.94
Allarity Therapeutics, Inc. · NASDAQ:ALLRUS$12.56MUS$21.48Mn/a61.4×n/an/an/an/a1.40
Lobe Sciences Ltd · CSE:LOBEUS$12.52MUS$8.89Mn/an/an/a9.5×n/a0.0×0.31
MIRA Pharmaceuticals, Inc. · NASDAQ:MIRAUS$12.23MUS$5.26Mn/an/an/a1.8×n/a0.0×1.48
Genflow Biosciences PLC · LSE:GENFUS$12.06MUS$11.24Mn/an/an/a48.5×n/a0.0×n/a
Median of the othersUS$12.63MUS$11.91M11.0×2.2×−204.1%0.0×0.61

Forecasts

Analysts' consensus from EODHD, read Nov 11, 2026. Not 6ix's view and not investment advice.

Price target
2.20 EUR · Analysts' mean
EPS, year to Dec 2025
-1.89 · 1 analyst

Team and board

Officers

OfficerRole
Stanislas VEILLETChairman – CEO
Christophe COURTILLATChief Financial Officer
Waly DIOHChief Operating Officer
Edouard BIETHChief Strategy Officer
Pierre J. DILDAChief Scientific Officer
Pr. Jean MARIANIChief Medical Officer

Board

DirectorRole
Stanislas VEILLETChairman – CEO
Claude ALLARY
Nadine COULM
Pr. Jean MARIANIChief Medical Officer

Events

QuarterResultsShare move
Quarter to Dec 31, 2025Feb 23, 2026−5.2%
Quarter to Sep 30, 2025Oct 31, 2025−2.6%
Q2 2025Sep 29, 2025 · Before open−3.5%
Quarter to Mar 31, 2025May 30, 2025−2.3%
Q4 2024Mar 31, 2025−2.8%
Quarter to Sep 30, 2024Nov 27, 2024+2.4%
Q2 2024Sep 30, 2024−0.0%
Q1 2024Apr 8, 2024−3.6%
Q4 2023Feb 26, 2024−2.4%
Q3 2023Oct 23, 2023 · After close−4.3%
All 20 quarters
QuarterResultsShare move
Q2 2023Jul 21, 2023 · Before open−1.4%
Q1 2023Apr 18, 2023 · Before open−10.3%
Q4 2022Feb 27, 2023+5.8%
Q3 2022Oct 31, 2022 · After close−2.1%
Q1 2022May 26, 2022 · After close+0.1%
Q4 2021Feb 26, 2022+4.0%
Q3 2021Dec 1, 2021−6.3%
Q2 2021Sep 17, 2021 · Before open−0.6%
Q1 2021May 20, 2021+4.9%
Q4 2020Feb 26, 2021 · Before open+4.8%

Open Events

Decks

DeckKindSlidesDate
Investor Presentation (August 2026)Investor deck19 slidesAugust 2026
Investor Presentation (August 2026)Investor deck19 slidesAugust 2026
Investor Presentation (March 2026)Investor deck21 slidesMarch 2026
Investor Presentation (March 2026)Investor deck21 slidesMarch 2026
Investor Presentation (January 2025)Investor deck32 slidesJanuary 2025
Investor Presentation (December 2024)Investor deck48 slidesDec 6, 2024
Investor Presentation (May 2024)Investor deck43 slidesMay 2024
Investor Presentation (May 2024)Investor deck43 slidesMay 2024
Investor Presentation (January 2024)Investor deck25 slidesJanuary 2024
Investor Presentation (January 2024)Investor deck25 slidesJanuary 2024
All 35 decks
DeckKindSlidesDate
Investor Presentation (November 2023)Investor deck25 slidesNovember 2023
Investor Presentation (September 2023)Investor deck25 slidesSeptember 2023
American Thoracic Society 2023Conference13 slidesMay 24, 2023
Investor Presentation (June 2022)Investor deck10 slidesJun 3, 2022
Investor Presentation (June 2022)Investor deck10 slidesJun 3, 2022
Shareholder Meeting (May 2021)Shareholder meeting26 slidesMay 10, 2021
Shareholder Meeting (May 2021)Shareholder meeting27 slidesMay 10, 2021
Shareholder Meeting (April 2021)Shareholder meeting16 slidesApr 26, 2021
Shareholder Meeting (April 2021)Shareholder meeting16 slidesApr 26, 2021
IPO Roadshow (February 2021)IPO roadshow18 slidesFeb 3, 2021
Investor Presentation (February 2021)Investor deck29 slidesFebruary 2021
Investor Presentation (February 2021)Investor deck29 slidesFebruary 2021
Investor Presentation (January 2021)Investor deck29 slidesJanuary 2021
Investor Presentation (January 2021)Investor deck29 slidesJanuary 2021
Investor Presentation (March 2020)Investor deck33 slidesMarch 2020
Investor Presentation (January 2020)Investor deck33 slidesJan 27, 2020
ICFSR 2020Conference13 slides2020
Investor Presentation (September 2019)Investor deck27 slidesSeptember 2019
IPO Roadshow (July 2019)IPO roadshow32 slidesJul 9, 2019
ICFSR 2019 Biophytis Lunch Industry SymposiumConference21 slidesFeb 21, 2019
ICFSR 2018 MiamiConference23 slidesMarch 2018
JPM 2018Conference31 slidesJanuary 2018
EURETINA 2017Conference6 slidesSeptember 2017
Investor Presentation (June 2016)Investor deck27 slidesJune 2016
Investor Presentation (June 2016)Investor deck27 slidesJune 2016

Open Decks

Financials

Annual, in EUR

Income statement

LineFY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016FY2015
Revenue0000000000
Cost of revenue298.0K803.0K484.0K311.0K280.0K262.0K227.0K204.0K167.0K65.0K
Gross profit-298.0K-803.0K-484.0K-311.0K-280.0K-262.0K-227.0K-204.0K-167.0K-65.0K
Research and development4.47M10.4M16.0M19.7M9.92M9.09M9.51M7.04M5.12M1.57M
Selling, general and administrative5.12M5.49M7.24M7.15M4.02M6.59M4.35M2.87M2.82M3.07M
Operating income-8.50M-14.3M-23.3M-26.8M-13.9M-15.7M-13.9M-9.91M-7.94M-3.10M
Depreciation and amortization298.0K803.0K484.0K311.0K280.0K262.0K227.0K204.0K167.0K65.0K
EBITDA-8.20M-13.5M-22.8M-26.5M-13.7M-15.4M-13.6M-9.70M-7.78M-3.03M
Interest expense872.0K1.25M1.60M4.43M4.37M2.53M185.0K3.29M35.0K172.5K
Income before tax-10.4M-18.6M-24.2M-31.2M-25.5M-17.8M-14.1M-11.4M-7.95M-3.29M
Income tax-1.15M-1.56M-3.41M2.28M-3.33M-28.0K-72.0K1.50M13.0K65.0K
Net income-10.4M-17.0M-24.2M-33.5M-25.5M-18.9M-14.0M-11.4M-7.95M-5.23M
Earnings per share, basic-2.00-12.54-55.40-113.38-170.19-448.88-418.32-496.65-512.93-430.09

Balance sheet

LineFY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016FY2015
Cash and equivalents78.0K5.57M11.1M23.9M5.85M6.34M14.4M19.9M3.07M9.41M
Short-term investments190.0K368.0K590.0K1.23M12.5M475.0K5.00M10.0M367
Receivables3.47M2.74M5.36M5.12M5.21M7.85M4.69M3.33M2.67M1.19M
Inventory45.0K1.57M-709.0K29.0K46.0K160.0K212.4K
Current assets3.92M8.85M18.6M31.4M24.0M14.7M19.4M23.4M5.89M10.8M
Property, plant and equipment231.0K315.0K584.0K563.0K114.0K185.0K295.0K313.0K276.0K194.0K
Total assets6.90M12.0M22.0M36.3M27.2M17.7M21.9M25.9M8.39M13.5M
Accounts payable4.28M5.39M6.94M7.61M7.99M7.87M4.87M2.40M1.92M701.0K
Current liabilities15.6M12.4M19.3M22.8M22.9M19.7M8.28M3.94M2.91M1.42M
Long-term debt673.0K2.42M4.18M6.07M1.83M5.40M6.38M661.0K820.0K272.0K
Total debt9.84M8.27M14.6M17.6M9.10M15.2M8.20M1.01M1.09M802.8K
Total liabilities16.6M15.8M23.9M30.6M20.4M25.2M14.9M4.76M3.87M1.85M
Shareholders' equity-9.67M-3.86M-1.88M5.83M2.30M-7.54M7.04M21.2M4.55M11.7M
Shares outstanding5.19M1.36M437.1K295.7K149.9K42.2K33.4K23.0K15.5K12.2K

Cash flow

LineFY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016FY2015
Cash from operations-8.64M-12.9M-19.0M-23.8M-9.86M-15.3M-12.1M-8.73M-6.63M-3.21M
Capital spending-9.15M-220.0K-141.0K-344.0K-214.0K-282.0K-113.0K-128.0K-129.0K-6.19K
Free cash flow-8.64M-13.1M-19.1M-24.1M-10.1M-15.6M-12.2M-8.86M-6.76M-3.22M
Cash from investing10.0K370.0K-17.0K12.2M-12.7M-278.0K-104.0K-128.0K-129.0K-6.19K
Cash from financing3.14M7.03M6.13M29.7M22.0M7.50M6.77M25.6M407.0K12.6M
Dividends paid0000000
Share buybacks5.54M16.6M23.5M21.8M-280.0K12.3M
Change in cash-5.49M-5.49M-12.9M18.1M-490.0K-8.07M-5.45M16.8M-6.34M9.42M

Open Financials

Filings

Open Filings

Cap table

Built by 6ix from Biophytis SA’s releases

Common shares
373,853,783
Fully diluted
373,853,783

Fully diluted

LineShares
Common shares373,853,783

Share count over time

CountShares
Nov 22, 2026373,853,783

Open Cap table

Shareholders

HolderSharesValueChange vs Jun 30Filed
Rhumbline Advisers9US$2No changeNov 10, 2026

Open Shareholders

People

6ix reads each seat by machine from the page it links to, and can misread one.

PersonSeat
Christophe COURTILLATChief Financial Officer · Since at least Nov 5, 2026
Claude ALLARYDirector · Since at least Nov 5, 2026
Edouard BIETHChief Strategy Officer · Since at least Nov 5, 2026
Nadine COULMDirector · Since at least Nov 5, 2026
Pierre J. DILDAChief Scientific Officer · Since at least Nov 5, 2026
Pr. Jean MARIANIChief Medical Officer · Since at least Nov 5, 2026
Stanislas VEILLETChairman – CEO · Since at least Nov 5, 2026
Waly DIOHChief Operating Officer · Since at least Nov 5, 2026

Open People

Log in to ask 6ix AI your own questions about Biophytis SA.